Phase 3 Trial of Blinatumomab vs Standard Chemotherapy in Pediatric Subjects With HIgh-Risk (HR) First Relapse B-precursor Acute Lymphoblastic Leukemia (ALL)
Amgen
Amgen
National Hospital Organization Nagoya Medical Center
Rigshospitalet, Denmark
M.D. Anderson Cancer Center
Children's Hospital of Philadelphia
National Cancer Institute (NCI)
Fred Hutchinson Cancer Center